Multimax wins Air Force software deal

Multimax Inc. has won a $6.2 million contract from the Air Force to provide software licenses for the Remedy Action Request System, the company announced today.

The order to Multimax of Largo, Md., fulfills Air Force requirements for additional Remedy ARS software licenses for the ongoing Combat Information Transport System, or CITS.

Remedy ARS, a call-tracking system for customer service inquiries, is the previously selected trouble-ticketing system supporting CITS. CITS is a multiyear, multibillion-dollar Air Force program focused on using commercial products to modernize IT at the base level.

The order was issued to Multimax Dec. 28 under the Air Force Network-Centric Solutions contract, known as Netcents. The company is one of eight prime contractors for the contract.

Multimax provides IT services and solutions to federal, state and local government. The various components of the Defense Department are the company's largest customers.

About the Author

William Welsh is a freelance writer covering IT and defense technology.

Reader Comments

Please post your comments here. Comments are moderated, so they may not appear immediately after submitting. We will not post comments that we consider abusive or off-topic.

Please type the letters/numbers you see above

What is your e-mail address?

My e-mail address is:

Do you have a password?

Forgot your password? Click here
close

Trending

  • VIDEO: Explore the 2019 M&A Trends

    Editor Nick Wakeman interviews Kevin DeSanto of the investment bank KippsDeSanto about the highlights of their annual M&A survey and trends driving acquisitions in the federal space. Read More

  • PROJECT 38 PODCAST

    In our latest Project 38 Podcast, editor Nick Wakeman and senior staff writer Ross Wilkers discuss the major news events so far in 2019 and what major trends are on the horizon. Read More

contracts DB

Washington Technology Daily

Sign up for our newsletter.

Terms and Privacy Policy consent

I agree to this site's Privacy Policy.